Table 5.
Most commonly used drugs for treatment of hypertensive emergencies in pregnancy.
Adapted from Ref. [55]
Drug | Route | Onset of action | Duration of action | Starting dose | Titration dose | Maximum dose | Perinatal concerns | Contra-indications | Adverse effects |
---|---|---|---|---|---|---|---|---|---|
Labetalol | iv (intermittent) | 5–10 min | 2–6 h | 10–20 mg iv (over 2 min) |
20–80 mg iv every 20–30 min |
300 mg | Foetal distress secondary to abrupt maternal hypotension; neonatal bradycardia and hypoglycaemia | II or III degree AV block; systolic heart failure; asthma; bradycardia | Bronchoconstriction (CAUTION in women with asthma); foetal bradycardia; postural hypotension; sleep disturbances; rebound hypertension; masking hypoglycaemia |
iv (infusion) | 1-2 mg/min | Increase by 1 mg/min every 10 min | |||||||
Hydralazine | iv (intermittent) | 10 min | 12 h | 5 mg/ iv or im | 5–10 mg iv every 20–40 min | 30 mg | Foetal distress secondary to abrupt maternal hypotension; caesarian section; abruption; APGAR score < 7 more common; rarely neonatal thrombocytopenia and neonatal lupus |
Headache; palpitations; tachycardia; nausea/vomiting; flushing; hypotension; lupus-like syndrome; CAUTION: side effects may mimic worsening pre-eclampsia |
|
Nifedipine short acting formulation |
Oral | 5–10 min | 2–4 h | 10–20 mg | Repeat in 30 min if needed | 30 mg | Foetal distress secondary to abrupt maternal hypotension; increased liver clearance may require higher doses | Uncontrolled hypotension (high when combined with magnesium sulphate); stroke; M (particularly when given sublingually); headache; flushing; reflex tachycardia | |
Nitroglycerine | iv (infusion) | 1-5 min | 3–5 min | 5 µg/min | Increase by 5 µg/min every 5 min | 200 µg/min | Headache; reflex tachycardia | ||
Esmolol | iv (infusion) | < 1 min | 15–30 min | Bolus 500 µg/kg; maintenance 50 µg/kg/min | Increase by 50 µg/kg/min every 4 min | 300 µg/kg/min | Foetal bradycardia; resistant foetal beta-blockade | II or III degree AV block; systolic heart failure; asthma; bradycardia | First-degree heart block; maternal bradycardia; CHF; bronchospasm |
Nicardipine | iv (infusion) | 1-5 min | 4–6 h | 5 mg/h | Increase by 2.5 mg/h every 5-15 min | 15 mg/h | liver failure | Tachycardia; flushing; headache | |
Urapidil | iv (infusion) | 3-5 min | 4–6 h | Bolus 12.5-25 mg; maintenance 5-40 mg/h | 40 mg/h | ||||
Sodium nitroprusside | iv (infusion) | < 1 min | 2–3 min | 0.25 µg/kg/min | Increase by 0.25-0.5 µg/kg/min every 2-3 min | 5 µg/kg/min | Foetal cyanide and thiocyanide toxicity if used > 4 h | Nausea; vomiting |
AV atrioventricular, CHF chronic heart failure, iv intravenous, im intramuscular, NO nitric oxide